Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background: Tonsillitis and quinsy remains a common acute in-patient admission into an Otolaryngology unit. Nevertheless, there
is lack of specific guidelines for secondary care. Resource utilization within the secondary care remains puzzling.
Aim: The primary aim was to assess our centre 2014 practice regarding throat swabs/pus sample (TSPS) and Monospot test (MT) for
tonsillitis and quinsy. The secondary aim was to analyze the effect of the investigations on the management.
Methodology: Retrospective data collection from the year 2014 was performed from a single ENT unit. List for patients admitted and
diagnosed with �Tonsillitis�, �Quinsy�, �Peritonsilar Abscess� or �Glandular Fever� was obtained from the Hospital Information Office.
The Electronic Care Record system was used to obtain the data needed. Fisher�s Exact were performed to analyze the data.
Results: 69 patients accounting for 72 episodes of admission occur in the year 2014. Mean age was 27.87 years old with Male: Female
ratio of 38:31. Overall, 35.2% did not have any investigation. 64.8% had at least more than one investigation accounting for 25% of
TSPS and 48.6% MT. The amount of investigations perform did not change the management (Fisher�s exact F=0.5973). The estimated
overall cost to detect one positive monospot test per 100 patients was 911.76gBP and 450gBP to grow a positive throat swab/pus
sample per 100 patients.
Conclusion: MT should only be performed in those within a high risk group patient. TSPS are not routinely sent as it will not alter
the management in 48 hours.